BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2229493)

  • 1. Cutaneous manifestations of postthymic T cell malignancies: description of five clinicopathologic subtypes.
    Su IJ; Wu YC; Chen YC; Hsieh HC; Cheng AL; Wang CH; Kadin ME
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 1):653-62. PubMed ID: 2229493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma.
    Su IJ; Tsai TF; Cheng AL; Chen CC
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):685-92. PubMed ID: 8227539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
    Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
    Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the spectrum of postthymic T-cell malignancies in Taiwan. A clinicopathologic study of HTLV-1-positive and HTLV-1-negative cases.
    Su IJ; Wang CH; Cheng AL; Chen YC; Hsieh HC; Chen CJ; Tien HF; Woei-Tsay ; Huang SS; Hu CY
    Cancer; 1988 May; 61(10):2060-70. PubMed ID: 2896068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
    Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
    Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Clinical, histopathologic, and immunohistochemical analyses.
    Nagatani T; Matsuzaki T; Iemoto G; Kim S; Baba N; Miyamoto H; Nakajima H
    Cancer; 1990 Dec; 66(11):2380-6. PubMed ID: 2245393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cutaneous lymphomas in a medical center in Bahia, Brazil.
    Bittencourt AL; Oliveira PD; Andrade AC; Santos TC; Oliveira RF; Farré L; Araujo I
    Am J Clin Pathol; 2013 Sep; 140(3):348-54. PubMed ID: 23955453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous peripheral T-cell lymphomas, unspecified/NOS and rare subtypes: a heterogeneous group of challenging cutaneous lymphomas.
    Kempf W; Rozati S; Kerl K; French LE; Dummer R
    G Ital Dermatol Venereol; 2012 Dec; 147(6):553-62. PubMed ID: 23149701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
    Olsen EA
    Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of cutaneous lymphomas in Osaka, Japan (1988-1999) based on the European Organization for Research and Treatment of Cancer classification.
    Nagasawa T; Miwa H; Nakatsuka S; Itami S; Yoshikawa K; Aozasa K
    Am J Dermatopathol; 2000 Dec; 22(6):510-4. PubMed ID: 11190442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
    Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
    J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia-lymphoma: Comparison between cutaneous type and other subtypes.
    Yonekura K; Utsunomiya A; Seto M; Takatsuka Y; Takeuchi S; Tokunaga M; Kubota A; Takeda K; Kanzaki T; Uchida Y; Kawai K; Kanekura T
    J Dermatol; 2015 Dec; 42(12):1143-8. PubMed ID: 26134467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases.
    Bittencourt AL; Barbosa HS; Vieira MD; Farré L
    Acta Oncol; 2009; 48(4):598-604. PubMed ID: 19165640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the γδ phenotype from Japan.
    Takahashi Y; Takata K; Kato S; Sato Y; Asano N; Ogino T; Hashimoto K; Tashiro Y; Takeuchi S; Masunari T; Hiramatsu Y; Maeda Y; Tanimoto M; Yoshino T
    Cancer Sci; 2014 Jul; 105(7):912-23. PubMed ID: 24815502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
    Amber KT; Bloom R; Nouri K
    Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.